The Influence of Shear Stress on Endothelial Cell Function in Engineered Vessels

Vascular tissue engineering holds great promise for creating living blood vessel substitutes to treat cardiovascular disease, the leading cause of death globally. A central challenge in this field is achieving a functional and durable endothelium—the monolayer of endothelial cells (ECs) lining the vessel lumen. In natural vessels, ECs are constantly exposed to hemodynamic forces, particularly shear stress, the frictional force exerted by blood flow. This mechanical stimulus is not merely a passive background condition but an active regulator of endothelial phenotype, gene expression, and long-term vessel health. Understanding how shear stress governs EC function is therefore essential for designing engineered vessels that can resist thrombosis, maintain patency, and integrate seamlessly with host tissue. This article explores the biophysics of shear stress, its profound effects on EC biology, and how these insights inform the cultivation of robust, functional vascular grafts.

Defining Shear Stress in the Vascular Context

Shear stress (τ) is defined as the tangential force per unit area generated by fluid flow across a surface. In blood vessels, the flowing blood creates a frictional drag along the endothelial surface. The magnitude of wall shear stress (WSS) in straight, cylindrical vessels is approximated by the Hagen-Poiseuille equation: τ = 4μQ/πr³, where μ is blood viscosity, Q is flow rate, and r is vessel radius. In the human arterial system, physiological WSS typically ranges from 10 to 70 dyn/cm² (1–7 Pa), depending on the vessel caliber and local flow dynamics. In the venous system, WSS is lower (1–6 dyn/cm²). Importantly, shear stress is not uniform: branches, curvatures, and bifurcations create complex flow patterns, with regions of disturbed flow (low and oscillatory shear) predisposing to endothelial dysfunction and atherosclerosis.

Two broad categories of shear stress are recognized in vascular biology: laminar (unidirectional, steady or pulsatile) and disturbed (turbulent or reversing). Laminar shear stress, typical of straight arterial segments, is atheroprotective and promotes a quiescent, anti-inflammatory EC phenotype. Disturbed flow, found at branch points, is proatherogenic and activates inflammatory signaling. For engineered vessels, achieving laminar, physiologically relevant shear stress is critical for proper EC maturation. Researchers often use computational fluid dynamics (CFD) models to predict WSS distributions in bioreactor systems and optimize flow parameters accordingly.

Mechanotransduction: How Endothelial Cells Sense Shear

ECs are equipped with an array of mechanosensors that convert mechanical forces into intracellular biochemical signals. Key components include:

  • The glycocalyx: A surface layer of proteoglycans and glycoproteins that transmits shear forces to the cortical cytoskeleton and activates nitric oxide synthase (eNOS).
  • Primary cilia: Microtubule-based organelles that bend in response to flow and trigger calcium influx and signaling cascades.
  • Integrin-based adhesions: Focal adhesions at cell-matrix junctions sense shear-induced tension and activate MAPK and PI3K/Akt pathways.
  • Intercellular junctional proteins: PECAM-1, VE-cadherin, and VEGFR2 form a mechanosensory complex that responds to flow by phosphorylating Akt and eNOS.
  • Ion channels: Piezo1, TRPV4, and other stretch-activated channels allow calcium entry and influence cytoskeletal remodeling.

These sensors converge on transcriptional programs governed by flow-sensitive transcription factors, most notably KLF2 (Kruppel-like factor 2). KLF2 is upregulated by laminar shear stress and acts as a master regulator of the anti-inflammatory, antithrombotic, and vasoprotective gene program. For a detailed review of mechanotransduction in ECs, see this comprehensive article in Nature Reviews Cardiology.

Effects of Shear Stress on Endothelial Cell Phenotype

Cell Alignment and Cytoskeletal Remodeling

One of the most striking responses to sustained laminar shear stress is the alignment of ECs in the direction of flow. Within hours to days, cells elongate and reorient their actin stress fibers, microtubules, and intermediate filaments to minimize drag. This morphological change reduces turbulence at the vessel surface and is a hallmark of a mature, functional endothelium. In contrast, ECs exposed to disturbed flow remain cobblestone-shaped and disorganized. Alignment is mediated by the reorganization of focal adhesions and the activation of Rho family GTPases (RhoA, Rac1, Cdc42). During engineered vessel culture, alignment is often used as a surrogate marker for effective mechanical conditioning.

Gene Expression Profiles: From Pro-Inflammatory to Protective

Laminar shear stress profoundly alters EC gene expression. Genes that are upregulated under physiological flow include:

  • eNOS: Produces nitric oxide (NO), a potent vasodilator and inhibitor of platelet aggregation and leukocyte adhesion.
  • Thrombomodulin and tissue plasminogen activator (tPA): Promote anticoagulant and fibrinolytic properties.
  • KLF2 and KLF4: Transcriptional repressors of inflammatory genes.
  • Superoxide dismutase (SOD): Antioxidant enzyme.

Conversely, disturbed flow or low shear stress upregulates pro-inflammatory molecules such as VCAM-1, ICAM-1, E-selectin, and MCP-1, promoting monocyte adhesion and the initiation of atherosclerosis. These changes highlight the dual role of shear stress as either a guardian of vascular health or a contributor to disease, depending on its spatial and temporal nature.

Barrier Function and Paracellular Permeability

Shear stress also modulates the integrity of EC junctions. Laminar shear stress strengthens adherens junctions (VE-cadherin) and tight junctions (claudins, occludins), reducing endothelial permeability. This is crucial for engineered vessels to prevent hemorrhage and control mass transport. Disturbed flow, on the other hand, downregulates junctional proteins and increases paracellular leakage. The regulation of the actin cytoskeleton and the small GTPase Rap1 plays a central role in shear-mediated junctional stabilization.

Antithrombotic and Vasoactive Functions

The endothelium’s ability to resist thrombosis is directly enhanced by laminar shear stress. NO and prostacyclin (PGI2) are both produced in response to flow and inhibit platelet activation and aggregation. Additionally, shear stress upregulates the expression of CD39 and CD73, ectonucleotidases that degrade pro-thrombotic ADP to anti-thrombotic adenosine. For engineered vessels, ensuring an antithrombotic surface through proper mechanical conditioning is a key strategy to avoid early graft failure. A landmark study demonstrated that pre-conditioning of endothelialized grafts with physiological shear stress significantly reduces platelet adhesion in ex vivo flow loops.

Engineering Blood Vessels: Incorporating Shear Stress into Culture Protocols

The challenge for tissue engineers is to recreate the complex mechanical environment of native vessels in an in vitro setting. Static culture often yields ECs that are poorly aligned, have reduced eNOS expression, and lack the full protective phenotype. Hence, dynamic conditioning in bioreactors is essential. Key considerations include:

Bioreactor Design and Flow Regimes

Several bioreactor configurations are used for vascular graft culture:

  • Parallel-plate flow chambers: Used for 2D studies; less relevant for tubular grafts but valuable for mechanistic research.
  • Cylindrical perfusion bioreactors: The scaffold or construct is mounted in a chamber and medium is pumped through the lumen. These can produce pulsatile flow with adjustable frequency and amplitude.
  • Rotating wall vessels: Provide uniform low-shear environments, often used for seeding ECs onto scaffolds before transitioning to higher shear.

Most protocols employ an incremental shear stress ramp—starting at low values (1–2 dyn/cm²) during cell seeding and adhesion, then gradually increasing to physiological ranges (10–20 dyn/cm²) over several days. This prevents cell detachment and induces orderly alignment. Pulsatile flow, with a systolic/diastolic waveform, more faithfully mimics arterial hemodynamics than steady flow and enhances EC maturation. For example, a 2021 study demonstrated that combined cyclic stretch and shear stress synergistically improved endothelial barrier function in engineered vessels.

Scaffold Material and Surface Topography

The substrate on which ECs are seeded also influences their response to shear. Natural polymers like collagen and fibrin provide integrin-binding sites that facilitate mechanotransduction. Synthetic polymers (e.g., PCL, PLA) can be functionalized with RGD peptides or coated with extracellular matrix proteins. Surface topography at the micro- or nanoscale can direct initial alignment, which is then reinforced by flow. Electrospun scaffolds with aligned fibers, for instance, induce EC orientation even before flow is applied, reducing the time needed for alignment under shear.

Monitoring Shear Stress and Endothelial Maturation

To ensure consistent conditioning, engineers must monitor flow parameters in real time and validate EC phenotype. Non-invasive techniques include:

  • Flow meters to confirm set rates.
  • Pressure sensors to calculate resistance and imply shear stress via Poiseuille's law (for straight tubes).
  • Micro-particle image velocimetry (µPIV) for detailed wall shear mapping in complex geometries.

Endothelial maturation is assessed through immunofluorescence (e.g., VE-cadherin, eNOS, actin alignment), quantitative PCR for KLF2 and thrombomodulin, and functional assays (NO production, barrier permeability, platelet adhesion under flow).

Optimization Strategies and Future Directions

Patient-Specific Flow Conditions

One emerging trend is the use of patient-specific hemodynamic data to program bioreactor flow profiles. For instance, a coronary artery bypass graft should be conditioned using the patient’s heart rate, pulse pressure, and cardiac output. Computational models can predict wall shear stress distribution in the graft, allowing for tailored conditioning that may improve long-term patency.

Co-Culture and Tri-Layered Vessel Models

Vascular grafts are not just endothelial tubes: they need a medial layer of smooth muscle cells (SMCs) and often an adventitia. Co-culture systems where ECs and SMCs are subjected to shear (for ECs) and cyclic stretch (for SMCs) more closely mimic the in vivo environment. Paracrine signaling between ECs and SMCs is also shear-sensitive; EC-derived NO relaxes SMCs, while SMC-derived factors influence EC quiescence. Engineering these interactions remains an active area of research.

Decellularized Vascular Scaffolds

Decellularized native vessels (e.g., from porcine or human donors) retain the natural extracellular matrix architecture, including the basement membrane that supports EC adhesion and alignment. Re-endothelialization of such scaffolds under physiological shear has shown promising results, with ECs recapitulating a quiescent phenotype. Combining decellularized scaffolds with patient-derived cells and bioreactor conditioning could accelerate clinical translation.

In Vitro Disease Modeling and Drug Testing

Engineered vessels conditioned with pathological shear patterns (e.g., low or oscillatory) can serve as disease models for atherosclerosis, in-stent restenosis, or venous graft failure. These platforms allow high-throughput screening of therapeutic compounds under controlled hemodynamic conditions, bridging the gap between 2D cultures and animal models.

Conclusion

Shear stress is not merely a physical parameter but a fundamental regulator of endothelial cell identity and function. From alignment and gene expression to barrier integrity and antithrombotic activity, the endothelial response to flow dictates whether a vessel remains healthy or degenerates. In the context of engineered blood vessels, mimicking physiological shear stress through well-designed bioreactor protocols is indispensable for producing grafts that are functional, durable, and capable of integrating into the host circulation. As the field moves toward personalized and clinically viable vascular replacements, a deep understanding of the interplay between mechanics and biology will continue to drive innovation. By embracing the complexity of hemodynamic forces and leveraging advances in bioreactor technology and cell biology, researchers are steadily overcoming the hurdles that have long limited the success of tissue-engineered vascular grafts.